In patients with<unk><unk>  angina, initial<unk>  investigations are used to: identify potential causes of ischemia, establish risk factors, and determine the overall prognosis for the patient. An initial<unk>  test can provide a wide variety of clinical information. For instance, low hemoglobin levels can cause ischemia. Therefore, assessing hemoglobin as a part of complete blood count provides prognostic information. Biomarkers, such as troponin and CK-MB, are used to exclude myocardial injury. In assessment for risk factor stratification, all patients with ischemic heart disease are recommended to have a a standard round of blood work conducted including fasting plasma glucose levels and a complete lipid profile. Serum creatinine is used to assess renal dysfunction due to associated hypertension or diabetes and remains a negative prognostic factor. In patients with<unk><unk>  angina, an elevation in fasting glucose independently predicts the adverse outcome. Recent research on NT-pro-BNP has demonstrated the ability to predict long-term mortality in patients with<unk><unk>  angina independent of age, ventricular ejection fraction and other risk factors.
Chronic stable angina laboratory findings
Chronic stable angina physical examination
Stress cardiomyopathy laboratory findings
Spontaneous coronary artery dissection physical examination
ST elevation myocardial infarction laboratory findings
Stress cardiomyopathy physical examination
Carcinoid syndrome electrocardiogram
Left ventricular aneurysm physical examination